Elevated serum levels of Chromogranin A in hepatocellular carcinoma

Antonio Biondi, Giulia Malaguarnera, Marco Vacante, Massimiliano Berretta, Velia Dagata, Michele Malaguarnera, Francesco Basile, Filippo Drago, Gaetano Bertino

Research output: Contribution to journalArticlepeer-review


Background: During the past three decades, the incidence of hepatocellular carcinoma in the United States has tripled. The neuroendocrine character has been observed in some tumor cells within some hepatocellular carcinoma nodules and elevated serum chromogranin A also been reported in patients with hepatocellular carcinoma. The aim of this work was to investigate the role of serum concentration of chromogranin A in patients with hepatocellular carcinoma at different stages. Methods. The study population consisted of 96 patients (63 males and 33 females age range 52-84) at their first hospital admission for hepatocellular carcinoma. The control group consisted of 35 volunteers (20 males and 15 females age range 50-80). The hepatocellular carcinoma patients were stratified according the Barcelona-Clinic Liver Cancer classification. Venous blood samples were collected before treatment from each patients before surgery, centrifuged to obtain serum samples and stored at -80° C until assayed. Results: The chromogranin A serum levels were elevated (> 100 ng/ml) in 72/96 patients with hepatocellular carcinoma. The serum levels of chromogranin A were significantly correlated (p

Original languageEnglish
Article numberS7
JournalBMC Surgery
Issue numberSUPPL. 1
Publication statusPublished - 2012

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Elevated serum levels of Chromogranin A in hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this